Patent intelligence · US
US 11180444
Polyimino ketoaldehydes
Polyimino ketoaldehydes
Patent details — US 11180444
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 23, 2021
- Expiration
- Nov 18, 2041
- Applicant
- NOVUM SPERO LTD
- Claims
- 19
- CPC classes
- A61P, A61P31/04, A61P31/06, A61P31/08
Quick answer
US 11180444 (Polyimino ketoaldehydes) is held by NOVUM SPERO LTD. Status: granted. Granted Nov 23, 2021. Expires Nov 18, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- NOVUM SPERO LTD
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61P, A61P31/04, A61P31/06, A61P31/08
More from NOVUM SPERO LTD
Related pharmaceutical patents in our USPTO index.
-
US 12428395
Heterocyclic compounds as kinase inhibitor and uses thereof
granted -
US 12291548
Compounds, compositions, and methods for the treatment of disease
granted -
US 12226403
Tebipenem pivoxil immediate and modified release oral dosage forms
granted -
US 12146004
Polymyxin compounds and uses thereof
granted -
US 12098155
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 12048691
High dosage tebipenem pivoxil tablet formulation
granted -
US 11718621
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 11459357
Polymyxin compounds
granted
Frequently asked questions
What is US patent 11180444?
US 11180444 (Polyimino ketoaldehydes) is held by NOVUM SPERO LTD. Status: granted. Granted Nov 23, 2021. Expires Nov 18, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11180444?
NOVUM SPERO LTD is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 16 pharmaceutical patents for this assignee.
When does US 11180444 expire?
Our index shows an expiration date of Nov 18, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.